Alpine Global Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,878
Closed -$310K 474
2024
Q2
$310K Buy
+11,878
New +$225K 0.05% 233
2022
Q4
Sell
-3,341
Closed -$97K 542
2022
Q3
$97K Buy
+3,341
New +$153K 0.02% 128
2022
Q2
Sell
-909
Closed -$92K 648
2022
Q1
$92K Buy
909
+40
+5% +$4.45K 0.02% 286
2021
Q4
$128K Buy
+869
New +$194K 0.02% 574
2021
Q3
Sell
-606
Closed -$280K 373
2021
Q2
$280K Sell
606
-1,208
-67% -$519K 0.04% 189
2021
Q1
$892K Buy
+1,814
New +$943K 0.09% 134

Other funds holding WGS

Alpine Global Management's WGS Position: Q3 2024 in Review

Alpine Global Management sold out of GeneDx Holdings (WGS) in Q3 2024, closing a stake of 11,878 shares — an estimated $310K sold.

Alpine Global Management first reported a position in WGS in Q1 2021 and held it in 6 quarters. The position peaked at $892K in Q1 2021. 136 funds tracked by Wall St. Rank hold WGS as of Q3 2024.

  • Alpine Global Management reported no remaining GeneDx Holdings position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 11,878 GeneDx Holdings shares in Q3 2024, an estimated $310K.
  • Alpine Global Management first reported a position in GeneDx Holdings in Q1 2021 and held it in 6 quarters.
  • Alpine Global Management's GeneDx Holdings position peaked at $892K in Q1 2021.
  • 136 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.